Related Experiment Videos
Randomized trials of coronary artery bypass surgery: impact on clinical practice at Duke University Medical Center
Insights
Coronary artery bypass grafting (CABG) practice patterns evolved post-trials, with surgical treatment increasing for severe left main stenosis but not moderate cases. Clinical decisions for CABG involve factors beyond trial data.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Clinical Practice Guidelines
Background:
- Major randomized trials have significantly influenced clinical decision-making for coronary artery bypass grafting (CABG).
- Understanding practice pattern shifts in response to these trials and other factors is crucial for optimizing patient care.
- Duke University Medical Center's experience provides a valuable case study for analyzing these trends.
Purpose of the Study:
- To assess changes in practice patterns for coronary artery bypass grafting (CABG) at Duke University Medical Center.
- To compare observed practice patterns with patient groups from major CABG randomized trials.
- To identify trends in CABG treatment independent of randomized trial outcomes.
Main Methods:
- Retrospective analysis of practice patterns at Duke University Medical Center.
- Comparison of treatment trends with patient cohorts from key randomized trials: Veterans Administration Cooperative Study, European Coronary Surgery Study, and Coronary Artery Surgery Study.
- Examination of the impact of percutaneous transluminal angioplasty and patient factors on treatment selection.
Main Results:
- Surgical treatment increased for patients with 75% or greater left main stenosis post-Veterans Administration Cooperative Study.
- Little change observed in surgical treatment rates for 50% left main stenosis.
- A trend towards surgical therapy for three-vessel disease with normal left ventricular function preceded the European Coronary Surgery Study, yet one-third still receive non-surgical treatment.
- Most eligible patients for the Coronary Artery Surgery Study have been treated non-surgically over the past decade.
- Percutaneous transluminal angioplasty use has increased, offering an alternative therapy.
- More patients with advanced age, unstable angina, or depressed ejection fraction undergo cardiac catheterization without trial support.
Conclusions:
- Randomized trials provide a strong evidence base for CABG, but clinical practice incorporates numerous other factors.
- Practice patterns evolve based on trial results, new interventions like angioplasty, and patient-specific characteristics.
- Further research may be needed to guide treatment for complex patient groups not covered by existing randomized trials.
Abstract:
Trends in practice patterns at Duke University Medical Center were assessed in patient groups comparable to those enrolled in the three major randomized trials of coronary artery bypass grafting (CABG). In addition, changes in practice patterns that appeared unrelated to the randomized trials were examined. Most patients with 75% or greater left main stenosis have been treated surgically after publication of the Veterans Administration Cooperative Study, but little change was noted in the proportion of patients with 50% left main stenosis who have been treated surgically. A trend towards selection of surgical therapy for patients with three-vessel disease and normal left ventricular function was evident before the publication of the European Coronary Surgery Study, although one-third of patients in this category continue to be treated nonsurgically after publication of the results of the trial. For the past decade, most patients who would have been eligible for the Coronary Artery Surgery Study have been treated nonsurgically. We have also documented trends in practice patterns that are independent of the results of randomized trials. The advent of percutaneous transluminal angioplasty has provided another therapeutic alternative that has been used increasingly. In addition, growing numbers of patients with advanced age, unstable angina, or markedly depressed left ventricular ejection fraction are being evaluated with cardiac catheterization despite the lack of supporting randomized trials. Randomized trials have placed our understanding of the effects of CABG on a sound foundation, but it is evident that clinicians continue to consider many other factors when therapeutic decisions are made.